随着时间的推移,免疫治疗改善了局部晚期和转移性皮肤状细胞癌的存活率
Sophie Schneider1, Thomas Ferte2, Océane Ducharme1
1Dermatology Department, Hôpital Saint André, CHU Bordeaux, 1 Avenue Jean-Burguet, 33000, Bordeaux, France.
Journal of cancer research and clinical oncology
|March 16, 2024
概括
晚期皮肤状细胞癌 (acSCC) 患者是老年和脆弱的. 随着时间的推移,观察到更好的生存率,免疫疗法显著降低了asSCC患者的死亡率和进展.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 流行病学 流行病学
背景情况:
- 皮肤状细胞癌 (cSCC) 是白皮肤个体中流行的一种癌症.
- 对于cSCC,特别是高级病例 (acSCC) 的流行病学数据有限.
研究的目的:
- 描述患有acSCC的患者的特征,治疗方法和结果.
- 分析随着时间的推移,acSCC患者群体的趋势.
主要方法:
- 一个单一中心的回顾性研究,对127名接受五年全身治疗的acSCC患者进行了5年.
- 患者被分为两个时间周期;亚组分析比较免疫疗法与非免疫疗法组.
主要成果:
- 从第1期 (10个月) 到第2期 (20个月) 的整体存活率 (OS) 显著改善.
- 免疫疗法显示,死亡率降低了71%,疾病进展率降低了67%.
- 晚年和免疫抑制与无进展生存率 (PFS) 的降低有关.
结论:
- acSCC患者通常是老年人和虚弱,并患有并发症.
- 随着时间的推移,改善的生存状况是由于获得免疫治疗的机会增加.
- 虽然OS有所改善,但PFS没有出现类似的增加,这凸显了对进展的更有效治疗的需要.
相关概念视频
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K


